Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Nilsen

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Frontiers in Veterinary Science|March 13, 2020
Activities of Endochin-Like Quinolones Against <i>in vitro</i> Cultured <i>Besnoitia besnoiti</i> TachyzoitesNaja Eberhard, Vreni Balmer, Joachim Müller, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2020
Orally Bioavailable Endochin-Like Quinolone Carbonate Ester Prodrug Reduces Toxoplasma gondii Brain CystsJ Stone Doggett, Tracey Schultz, Alyssa J Miller, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2012
Sontochin as a guide to the development of drugs against chloroquine-resistant malariaSovitj Pou, Rolf W Winter, Aaron Nilsen, et al.
Future Medicinal Chemistry|November 9, 2022
2-hydroxy-1,4-naphthoquinones with 3-alkyldiarylether groups: synthesis and <i>Plasmodium falciparum</i> inhibitory activityAmanda Berg, Chelsea B Swartchick, Noah Forrest, et al.
ACS Infectious Diseases|August 18, 2018
Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc<sub>1</sub> and Identifies ELQ-400 as a Remarkably Effective Compound against Acute Experimental ToxoplasmosisErin V McConnell, Igor Bruzual, Sovitj Pou, et al.
Journal of Virology|December 22, 2017
Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING PathwayBryan Gall, Kara Pryke, Jinu Abraham, et al.
Antimicrobial Agents and Chemotherapy|June 9, 2016
Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for MalariaAllison M Stickles, Martin J Smilkstein, Joanne M Morrisey, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 10, 2024
Long-acting intramuscular injections of ELQ-331, an antimalarial agentDipu Karunakaran, Shravan K Mutyam, Melody Fu, et al.
Organic Process Research & Development|February 3, 2022
A New Scalable Synthesis of ELQ-300, ELQ-316, and other Antiparasitic QuinolonesSovitj Pou, Rozalia A Dodean, Lisa Frueh, et al.
Antimicrobial Agents and Chemotherapy|January 22, 2015
Subtle changes in endochin-like quinolone structure alter the site of inhibition within the cytochrome bc1 complex of Plasmodium falciparumAllison M Stickles, Mariana Justino de Almeida, Joanne M Morrisey, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Frontiers in Veterinary Science|March 13, 2020
Activities of Endochin-Like Quinolones Against <i>in vitro</i> Cultured <i>Besnoitia besnoiti</i> TachyzoitesNaja Eberhard, Vreni Balmer, Joachim Müller, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2020
Orally Bioavailable Endochin-Like Quinolone Carbonate Ester Prodrug Reduces Toxoplasma gondii Brain CystsJ Stone Doggett, Tracey Schultz, Alyssa J Miller, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2012
Sontochin as a guide to the development of drugs against chloroquine-resistant malariaSovitj Pou, Rolf W Winter, Aaron Nilsen, et al.
Future Medicinal Chemistry|November 9, 2022
2-hydroxy-1,4-naphthoquinones with 3-alkyldiarylether groups: synthesis and <i>Plasmodium falciparum</i> inhibitory activityAmanda Berg, Chelsea B Swartchick, Noah Forrest, et al.
ACS Infectious Diseases|August 18, 2018
Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc<sub>1</sub> and Identifies ELQ-400 as a Remarkably Effective Compound against Acute Experimental ToxoplasmosisErin V McConnell, Igor Bruzual, Sovitj Pou, et al.
Journal of Virology|December 22, 2017
Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING PathwayBryan Gall, Kara Pryke, Jinu Abraham, et al.
Antimicrobial Agents and Chemotherapy|June 9, 2016
Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for MalariaAllison M Stickles, Martin J Smilkstein, Joanne M Morrisey, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 10, 2024
Long-acting intramuscular injections of ELQ-331, an antimalarial agentDipu Karunakaran, Shravan K Mutyam, Melody Fu, et al.
Organic Process Research & Development|February 3, 2022
A New Scalable Synthesis of ELQ-300, ELQ-316, and other Antiparasitic QuinolonesSovitj Pou, Rozalia A Dodean, Lisa Frueh, et al.
Antimicrobial Agents and Chemotherapy|January 22, 2015
Subtle changes in endochin-like quinolone structure alter the site of inhibition within the cytochrome bc1 complex of Plasmodium falciparumAllison M Stickles, Mariana Justino de Almeida, Joanne M Morrisey, et al.
Pageof 6